AGENUS INC. - COMMON STOCK
0.5564
27-March-24 15:59:59
15 minutes delayed
Stocks
+0.0200
+3.73%
Today's range
0.5350 - 0.5623
ISIN
N/A
Source
NASDAQ
-
28 Feb 2023 07:30:00 By Nasdaq GlobeNewswire
-
Agenus to Participate in February Investor Conferences
26 Jan 2023 07:30:00 By Nasdaq GlobeNewswire
-
23 Jan 2023 07:30:00 By Nasdaq GlobeNewswire
-
Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference
10 Jan 2023 08:30:00 By Nasdaq GlobeNewswire
-
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
21 Dec 2022 08:30:00 By Nasdaq GlobeNewswire
-
17 Nov 2022 08:30:00 By Nasdaq GlobeNewswire
-
Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference
16 Nov 2022 08:30:00 By Nasdaq GlobeNewswire
-
14 Nov 2022 08:30:00 By Nasdaq GlobeNewswire
-
Agenus Provides Corporate Update and Third Quarter 2022 Financial Report
08 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report
25 Oct 2022 08:30:00 By Nasdaq GlobeNewswire
-
13 Oct 2022 08:32:28 By Nasdaq GlobeNewswire
-
12 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Agenus to Host “The Road Taken” R&D Event on November 12, 2022
05 Oct 2022 08:30:00 By Nasdaq GlobeNewswire
-
05 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
12 Sep 2022 08:30:00 By Nasdaq GlobeNewswire
-
Agenus Makes Senior Regulatory and Clinical Appointments
12 Sep 2022 08:30:00 By Nasdaq GlobeNewswire
-
Agenus Provides Corporate Update and Second Quarter 2022 Financial Report
09 Aug 2022 08:00:03 By Nasdaq GlobeNewswire
-
Agenus to Participate at BTIG Biotechnology Conference
02 Aug 2022 08:30:00 By Nasdaq GlobeNewswire
-
Agenus to Provide Corporate Update and Second Quarter 2022 Financial Report
27 Jul 2022 08:30:00 By Nasdaq GlobeNewswire
-
Agenus to Participate at William Blair’s Biotech Focus Conference
30 Jun 2022 08:30:00 By Nasdaq GlobeNewswire